Breathe Well Live Well
|
Sublingual Immunotherapy Not Currently Recommended For Asthma Control
Medical Research News and Interviews on MedicalResearch.com (blog) Response: Asthma is a common, long-term, respiratory condition which affects over 300 million people worldwide. It is a burden not only for the individual with asthma but also for the health services that care for them and the wider economy, due to … |
View full post on asthma – Google News
|
New care model for M?ori children with asthma recommended
Medical Xpress A new University of Otago, Wellington, research report has found that the main barriers to optimal health literacy—and therefore optimal care for M?ori children with asthma—are structural and endemic to New Zealand's acute care model of health delivery. |
View full post on asthma – Google News
|
New care model for M?ori children with asthma recommended – Medical Xpress
Medical Xpress A new University of Otago, Wellington, research report has found that the main barriers to optimal health literacy—and therefore optimal care for M?ori children with asthma—are structural and endemic to New Zealand's acute care model of health delivery. |
View full post on asthma – Google News
|
Study shows cost-effective expert recommended asthma test underutilized by …
Medical Xpress Researchers from the University of Texas Medical Branch at Galveston have found, for the first time, that spirometry was underutilized for asthma diagnosis and management in U.S. adults from 2001 to 2011, despite it's accuracy, cost effectiveness and … |
View full post on asthma – Google News
|
FDA Panels: Primatene HFA Inhaler Not Recommended for Asthma
Medscape "Many of the patients that come to tell me that they have asthma don't have asthma and would be using this product, and probably would be using it every day," Dr. Paasche-Orlow explained. E004 was intended to replace the OTC inhaler epinephrine metered … |
View full post on asthma – Google News
 Telegraph.co.uk |
Single Combined Asthma Inhaler Better Than Recommended Treatment
Medical News Today Using two asthma medications combined in a single inhaler provides superior rescue and preventive treatment than guideline-based treatments among adults whose asthma symptoms are not well controlled, according to two large, randomized clinical trials … Combo Inhaler May Give Better Relief for Some With Asthma Single inhaler asthma therapy better Dual-purpose asthma inhalers more effective |
View full post on asthma – Google News
 Telegraph.co.uk |
Recommended: Shadid's death highlights dangers of asthma
msnbc.com 16, 2012, apparently of an asthma attack, while on assignment for the New York Times in Syria, the paper said. He was 43. By Linda Carroll Journalist Anthony Shadid's sudden death has many wondering how an apparently healthy 43-year-old man could be … New York Times reporter Anthony Shadid dies in Syria after asthma attack New York Times Correspondent Shadid Dies in Syria The man who brought the Arab Spring home |
View full post on asthma – Google News
 MarketWatch |
Recommended: Q&A: Cats and cat allergies on a plane
msnbc.com “If I have an allergy attack, it manifests as asthma that could not only cause a trip to the hospital, at best, but also typically means I will be recovering for days after receiving treatment,” wrote Ambler. He tries to call ahead to see if there … Atchoo! How to battle dust-mite allergies |
View full post on asthma – Google News
|
PPIs Not Recommended for Routine Treatment of Adult Asthma
Medscape April 11, 2011 — Proton pump inhibitor (PPI) therapy in adults with asthma shows a small, statistically, but not clinically, significant improvement in the morning peak expiratory flow (PEF) rate, according to the results of a meta-analysis reported … The Efficacy of Proton Pump Inhibitors for the Treatment of Asthma in Adults A … |
View full post on asthma – Google News
 LiveScience.com |
Asthma Worse In Children, Novartis' Xolair Recommended
Medical News Today A new study suggests that Novartis drug Xolair may aid in the treatment of asthma, the leading cause of chronic illness in children, especially for those living in highly polluted inner-city areas. Asthma affects as many as 10% to 12% of children in … Omalizumab 'cuts seasonal asthma attacks in youth' Omalizumab improves asthma control in inner-city children Drug may relieve kids' asthma in the fall |
View full post on asthma – Google News